Literature DB >> 20394075

CD8alpha+ dendritic cells prime TCR-peptide-reactive regulatory CD4+FOXP3- T cells.

Trevor R F Smith1, Igor Maricic, Francesco Ria, Susan Schneider, Vipin Kumar.   

Abstract

CD4(+) T cells with immune regulatory function can be either FOXP3(+) or FOXP3(-). We have previously shown that priming of naturally occurring TCR-peptide-reactive CD4(+)FOXP3(-) Treg specifically controls Vbeta8.2(+)CD4(+) T cells mediating EAE. However, the mechanism by which these Treg are primed to recognize their cognate antigenic determinant, which is derived from the TCRVbeta8.2-chain, is not known. In this study we show that APC derived from splenocytes of naïve mice are able to stimulate cloned CD4(+) Treg in the absence of exogenous antigen, and their stimulation capacity is augmented during EAE. Among the APC populations, DC were the most efficient in stimulating the Treg. Stimulation of CD4(+) Treg was dependent upon processing and presentation of TCR peptides from ingested Vbeta8.2TCR(+)CD4(+) T cells. Additionally, DC pulsed with TCR peptide or apoptotic Vbeta8.2(+) T cells were able to prime Treg in vivo and mediate protection from disease in a CD8-dependent fashion. These data highlight a novel mechanism for the priming of CD4(+) Treg by CD8alpha(+) DC and suggest a pathway that can be exploited to prime antigen-specific regulation of T-cell-mediated inflammatory disease.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20394075      PMCID: PMC3031495          DOI: 10.1002/eji.200939608

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  47 in total

1.  Anti-TCR antibody treatment activates a novel population of nonintestinal CD8 alpha alpha+ TCR alpha beta+ regulatory T cells and prevents experimental autoimmune encephalomyelitis.

Authors:  Xiaolei Tang; Igor Maricic; Vipin Kumar
Journal:  J Immunol       Date:  2007-05-15       Impact factor: 5.422

2.  Less mortality but more relapses in experimental allergic encephalomyelitis in CD8-/- mice.

Authors:  D R Koh; W P Fung-Leung; A Ho; D Gray; H Acha-Orbea; T W Mak
Journal:  Science       Date:  1992-05-22       Impact factor: 47.728

3.  Major histocompatibility complex binding affinity of an antigenic determinant is crucial for the differential secretion of interleukin 4/5 or interferon gamma by T cells.

Authors:  V Kumar; V Bhardwaj; L Soares; J Alexander; A Sette; E Sercarz
Journal:  Proc Natl Acad Sci U S A       Date:  1995-10-10       Impact factor: 11.205

4.  MHC-restricted depletion of human myelin basic protein-reactive T cells by T cell vaccination.

Authors:  J Zhang; R Medaer; P Stinissen; D Hafler; J Raus
Journal:  Science       Date:  1993-09-10       Impact factor: 47.728

5.  Antigen-specific down-regulation of myelin basic protein-reactive T cells during spontaneous recovery from experimental autoimmune encephalomyelitis: further evidence of apoptotic deletion of autoreactive T cells in the central nervous system.

Authors:  Z Tabi; P A McCombe; M P Pender
Journal:  Int Immunol       Date:  1995-06       Impact factor: 4.823

Review 6.  Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.

Authors:  H L Weiner; A Friedman; A Miller; S J Khoury; A al-Sabbagh; L Santos; M Sayegh; R B Nussenblatt; D E Trentham; D A Hafler
Journal:  Annu Rev Immunol       Date:  1994       Impact factor: 28.527

7.  Immunodominant framework region 3 peptide from TCR V beta 8.2 chain controls murine experimental autoimmune encephalomyelitis.

Authors:  V Kumar; R Tabibiazar; H M Geysen; E Sercarz
Journal:  J Immunol       Date:  1995-02-15       Impact factor: 5.422

8.  Regulatory T cells specific for the same framework 3 region of the Vbeta8.2 chain are involved in the control of collagen II-induced arthritis and experimental autoimmune encephalomyelitis.

Authors:  V Kumar; F Aziz; E Sercarz; A Miller
Journal:  J Exp Med       Date:  1997-05-19       Impact factor: 14.307

9.  Inactivation of T cell receptor peptide-specific CD4 regulatory T cells induces chronic experimental autoimmune encephalomyelitis (EAE).

Authors:  V Kumar; K Stellrecht; E Sercarz
Journal:  J Exp Med       Date:  1996-11-01       Impact factor: 14.307

10.  The involvement of T cell receptor peptide-specific regulatory CD4+ T cells in recovery from antigen-induced autoimmune disease.

Authors:  V Kumar; E E Sercarz
Journal:  J Exp Med       Date:  1993-09-01       Impact factor: 14.307

View more
  3 in total

Review 1.  How tolerogenic dendritic cells induce regulatory T cells.

Authors:  Roberto A Maldonado; Ulrich H von Andrian
Journal:  Adv Immunol       Date:  2010       Impact factor: 3.543

2.  Global expression profiling of peripheral Qa-1-restricted CD8αα+TCRαβ+ regulatory T cells reveals innate-like features: implications for immune-regulatory repertoire.

Authors:  Shaohsuan S Fanchiang; Radu Cojocaru; Mohammad Othman; Ritu Khanna; Matthew J Brooks; Trevor Smith; Xiaolei Tang; Igor Maricic; Anand Swaroop; Vipin Kumar
Journal:  Hum Immunol       Date:  2011-08-17       Impact factor: 2.850

3.  Determining disease intervention strategies using spatially resolved simulations.

Authors:  Mark Read; Paul S Andrews; Jon Timmis; Richard A Williams; Richard B Greaves; Huiming Sheng; Mark Coles; Vipin Kumar
Journal:  PLoS One       Date:  2013-11-14       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.